ARTICLE | Company News
Avedro's ophthalmic solution gets Priority Review
November 26, 2013 1:20 AM UTC
Avedro Inc. (Waltham, Mass.) said FDA accepted and granted Priority Review to an NDA for riboflavin ophthalmic solution to treat keratoconus (structural degradation of the cornea) and corneal ectasia ...